On June 25 the American Medical Association's (AMA’s) House of Delegates adopted Resolution 522, which directs the AMA to "study the issue of direct to consumer advertising of genetics tests and the provision of genetics testing to patients on the Internet or other vehicles not directly involving the patient's physician, taking into consideration appropriate mechanisms to regulate this practice." The resolution was introduced by the American College of Obstetricians and Gynecologists and the Massachusetts Delegation. The AMA will study the issue over the next year and will likely issue a report to coincide with the 2008 annual meeting of its House of Delegates.
Read the resolution
Read the issue brief, “Direct-to-consumer testing: empowering or endangering the public?”